FDA Warning Letter — Haw Par Healthcare Limited
The FDA took a Warning Letter action against Haw Par Healthcare Limited on August 19, 2019 (Singapore, Singapore). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Haw Par Healthcare Limited
- Date
- August 19, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Center
- CDER
- Location
- Singapore (Singapore)